The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Management of Psoriatic Arthritis, Treatment of Axial Spondyloarthritis Addressed at EULAR 2016

Management of Psoriatic Arthritis, Treatment of Axial Spondyloarthritis Addressed at EULAR 2016

October 10, 2016 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Phil Mickelson, shown here at the 2009 US Open, in Farmingdale, N.Y., announced in August 2015 that he had been diagnosed with psoriatic arthritis, drawing national attention to the condition.

Phil Mickelson, shown here at the 2009 US Open, in Farmingdale, N.Y., announced in August 2015 that he had been diagnosed with psoriatic arthritis, drawing national attention to the condition.
David W. Leindecker/shutterstock.com

LONDON—Rheumatologists need to make the management of psoriatic arthritis (PsA) “a little more complex,” treating different tissues individually and doing more to help treat and prevent co-morbidities, an expert said here at the Annual Congress of the European League Against Rheumatism (EULAR) 2016.

You Might Also Like
  • Research on Ixekizumab in Psoriatic Arthritis and More Presented at EULAR 2016
  • EULAR 2015: Emerging Concepts, Treatments for Axial Spondyloarthritis
  • EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis
Explore This Issue
October 2016
Also By This Author
  • EULAR 2013: Researchers Make Inroads in Treatment of Osteoarthritis

Iain McInnes, MD, PhD, director of the Research Institute for Infection, Immunity and Inflammation at the University of Glasgow, reminded his audience during a scientific session that co-morbidities in PsA are all over the map, from cardiovascular disease to metabolic syndrome to gastrointestinal problems.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

And it’s the responsibility of the rheumatologist to stay on top of all aspects of the health issues that can arise from the disease, even if they aren’t his primary field, Dr. McInnes said.

“It is our job as rheumatologists to at least entertain the thought that such co-morbidities should be, one, recognized and, two, treated,” he said. “Every patient that comes to our clinic in Glasgow has their weight measured and their blood pressure measured and I ask about both of those elements of their life.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

And talk is empty if it isn’t followed by action, he said.

“If I tell them that losing weight is important but I never measure their weight, it’s like telling your teenager to go and tidy their bedroom,” he said. “The one thing that isn’t going to happen is that their bedroom is going to be tidied.”

The link between PsA and other processes in the body is tied to evolution, he said. As an example, he mentioned tumor necrosis factor and serotonin. Before medical advances, in order to heal, people needed quiet places to sleep to build up enough energy for their immune systems to fight off illness. So it shouldn’t be too surprising to learn, as a paper showed earlier this year, that circulating TNF is highly correlated to the bioavailability of serotonin in the brain.1

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“When a patient with psoriatic arthritis tells you they’re depressed—and by the way I would urge you to ask—they’re not telling you that they are only depressed about having the disease, which is an understandable reactive phenomenon; they’re actually telling you they comprise a biological syndrome whereby the brain and the peripheral inflammatory system are evolutionarily required to relate to each other and, therefore, unsurprisingly the patient’s syndrome comprises diminution of life satisfaction.”

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Meeting Reports Tagged With: axial spondyloarthritis (SpA), disease-modifying anti-rheumatic drugs, EULAR 2016, Management, patient care, Psoriatic Arthritis, rheumatology, TreatmentIssue: October 2016

You Might Also Like:
  • Research on Ixekizumab in Psoriatic Arthritis and More Presented at EULAR 2016
  • EULAR 2015: Emerging Concepts, Treatments for Axial Spondyloarthritis
  • EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis
  • Ustekinumab Improves Spondylitis in Patients with Psoriatic Arthritis

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)